Patent AnalyticsExaminers
Rankings

Company or institution

Merus N.V.

115 applicationsfiled 2006 to 2026

Allowance rate
83%
+7 pts vs the USPTO range 72% to 90%
Rejections before allowance
2.5
+0.9 vs the USPTO
Months to first action
22.8 mo
+4.2 vs the USPTO
Needed an RCE
56%
+29 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07K Peptides69 apps
A61P Therapeutic activity of compounds25 apps
A61K Medical preparations15 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids2 apps
A01K 1 apps
C40B 1 apps

Art units

164321 apps
163318 apps
164213 apps
164613 apps
OPAP9 apps
16447 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19621471ERBB-2 AND ERBB3 TARGETING AGENTS FOR USE IN THE TREATMENT OF MALIGNANT CELLS OR CA…2026-09-04Pending00n/a
19697449MULTIVALENT ANTIBODY2026-06-03Pending101.8 mo
19587625COMBINATION THERAPY INCLUDING ANTIBODIES THAT BIND EGFR AND CMET2026-05-14Pending00n/a
15820560Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15779547Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15168322Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15950628Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15129033Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15566136Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15586558Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 115 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in